Androgenic Alopecia - Androgenetic
Androgenetic alopecia In men, or male pattern baldness, is recognized increasingly as a physically and psychologically harmful medical condition. Androgenetic alopecia affects at least half of white men by the age of 50 years. Although androgenetic alopecia does not appear to cause direct physical harm, hair loss can result in physical harm because hair protects against sunburn, cold, mechanical injury, and ultraviolet light. Hair loss also can psychologically affect the balding individual and can Influence others' perceptions of him. A progressive condition, male pattern baldness is known to depend on the presence of the androgen dihydrotestosterone - DHT - and on a genetic predisposition for this condition. Medicines, hair transplantation, and cosmetic aids have been used to manage male pattern baldness. Two US Food and Drug Administration-approved hair-loss drugs - the potassium channel opener minoxidil and the dihydrotestosterone synthesis inhibitor finasteride -- are somewhat effective for controlling male pattern baldness with long-term daily use. Regardless of which treatment is chosen for alopecia, defining and addressing the patient's expectations regarding therapy are paramount in determining outcome.
Scalp Reduction: This is a process where the area of the bald skin is decreased on the head. With time, the skin on the head becomes stretchable and flexible enough so that small sections of this skin can be removed surgically. After the hairless portion of the scalp is removed, the space is closed with hair-covered scalp. This procedure takes time to show results. The scalp reduction method is usually used in combination with hair transplantation. This ensures a natural looking hairline. It is best for those with extensive hair loss.